Overview

Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study

Status:
Terminated
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
To assess the immunogenicity of Saizen® solution for injection in adult subjects with documented Growth Hormone Deficiency (GHD).
Phase:
Phase 3
Details
Lead Sponsor:
EMD Serono
Treatments:
Hormones